Summary of HR 1046 - Marc Fischer Memorial Act

Overview

The Marc Fischer Memorial Act (HR 1046) was introduced in the House of Representatives on February 6, 2025. The bill aims to enhance the safety and security of Federal correctional facilities by requiring the Director of the Bureau of Prisons to develop and implement a strategy to interdict fentanyl and other synthetic drugs that are smuggled through the mail.

Purpose and Intent

The primary purpose of the Marc Fischer Memorial Act is to address the growing concern over the introduction of synthetic drugs, particularly fentanyl, into Federal prisons via inmate mail. The bill seeks to protect the health and safety of both correctional staff and inmates, as well as to improve the overall security of correctional institutions.

Key Provisions

1. Evaluation Requirement:

   • The Director of the Bureau of Prisons must evaluate the current capabilities of Federal correctional facilities regarding synthetic drug interdiction technologies within 180 days of the bill's enactment.

2. Strategy Development:

   • Following the evaluation, the Director must submit a comprehensive strategy to Congress within 90 days. This strategy should include:
     • Protection measures for staff and inmates against synthetic drugs.
     • A timeline for digital mail scanning, ensuring inmates receive digital copies of their mail within 24 hours and original copies (if safe) within 30 days.
     • A process for handling legal mail that maintains attorney-client privilege.
     • Achieving 100% scanning capacity for all incoming mail.

3. Implementation Timeline:

   • The Bureau of Prisons is required to complete the implementation of the strategy within three years after the plan is submitted, contingent upon appropriations.

4. Annual Reporting:

   • The Director must provide annual progress reports to Congress starting one year after the strategy is submitted.

5. Budgetary Considerations:

   • The strategy must include a budget proposal for fiscal years 2025 through 2027 to support the necessary technology and operational changes.

Impact

The Marc Fischer Memorial Act is expected to:
- Enhance Safety: By reducing the influx of synthetic drugs into prisons, the bill aims to decrease drug-related incidents and overdoses, which have reportedly increased by 600% in recent years.
- Support Staff: The implementation of drug interdiction technologies is anticipated to alleviate the workload of correctional officers, allowing them to focus on other critical duties.
- Protect Inmates: Ensuring that inmates receive their mail in a timely and safe manner while preventing the introduction of dangerous substances.

Legislative Status

• The bill has been referred to the House Committee on the Judiciary for further consideration. It currently has a broad range of bipartisan cosponsors, indicating a collective interest in addressing the issues of drug smuggling in correctional facilities.

Conclusion

The Marc Fischer Memorial Act represents a proactive approach to tackling the serious issue of synthetic drug smuggling in Federal prisons. By mandating the development of a comprehensive interdiction strategy, the bill aims to safeguard the health and safety of both inmates and correctional staff, while also enhancing the security of correctional institutions across the United States.